The Searle Company Limited (PSX:SEARL)
Pakistan · Delayed Price · Currency is PKR 106.19
+1.25 (1.19%)
At close: Oct 21, 2025
The Searle Company Revenue
In the fiscal year ending June 30, 2025, The Searle Company had annual revenue of 28.60B PKR, down -2.72%. The Searle Company had revenue of 6.60B in the quarter ending June 30, 2025, a decrease of -7.25%.
Revenue
28.60B
Revenue Growth
-2.72%
P/S Ratio
2.18
Revenue / Employee
7.53M
Employees
3,799
Market Cap
62.46B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 28.60B | -800.84M | -2.72% |
| Jun 30, 2024 | 29.40B | 3.60B | 13.97% |
| Jun 30, 2023 | 25.80B | -4.11B | -13.75% |
| Jun 30, 2022 | 29.91B | 3.69B | 14.07% |
| Jun 30, 2021 | 26.22B | 5.74B | 28.06% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Abbott Laboratories (Pakistan) | 72.39B |
| GlaxoSmithKline Pakistan | 62.62B |
| Shifa International Hospitals | 27.97B |
| AGP Limited | 26.11B |
| Highnoon Laboratories | 25.78B |
| Ferozsons Laboratories | 18.86B |
| Citi Pharma | 13.15B |
| Macter International | 10.36B |